Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
The clinical potential of peptide therapeutic agents can only be fully realised once their physicochemical and pharmacokinetic properties are precisely controlled. Here the authors show a reversible peptide self-assembly strategy to control and prolong the bioactivity of a native peptide hormone in...
Saved in:
Main Authors: | Myriam M. Ouberai, Ana L. Gomes Dos Santos, Sonja Kinna, Shimona Madalli, David C. Hornigold, David Baker, Jacqueline Naylor, Laura Sheldrake, Dominic J. Corkill, John Hood, Paolo Vicini, Shahid Uddin, Steven Bishop, Paul G. Varley, Mark E. Welland |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/c7f770bfea9c44cf8e0311310d874e5d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biocompatibility pathways and mechanisms for bioactive materials: The bioactivity zone
by: David F. Williams
Published: (2022) -
Plant-Based Colloidal Delivery Systems for Bioactives
by: Yunbing Tan, et al.
Published: (2021) -
Fruit Derived Potentially Bioactive Bioengineered Silver Nanoparticles
by: Baker A, et al.
Published: (2021) -
A universal reporter cell line for bioactivity evaluation of engineered cytokine products
by: Jacqueline Mock, et al.
Published: (2020) -
The bone hormones and their potential effects on glucose and energy metabolism
by: Addai Daniel, et al.
Published: (2019)